Background Non‐absorbable disaccharides (lactulose and lactitol) are recommended as
first‐line treatment for hepatic encephalopathy. The previous (second) version of this review …

A “leaky gut” may be the cutting edge for the passage of toxins, antigens or bacteria into the
body, and may play a pathogenic role in advanced liver cirrhosis and its complications …

Background Hepatic encephalopathy is a chronically debilitating complication of hepatic
cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the …

Background/Aims: The efficacy and safety of rifaximin in comparison with lactitol in the
treatment of acute hepatic encephalopathy was assessed in a prospective randomized …

Background Progressive gut milieu (microbiota) changes occur in patients with cirrhosis and
are associated with complications [eg hepatic encephalopathy (HE)]. Aim To examine the …

Synopsis Rifaximin is a derivative of rifamycin which acts by inhibiting bacterial ribonucleic
acid (RNA) synthesis. It is virtually unabsorbed after oral administration; thus it is used …

Background and aims: In a recent open trial we have shown the efficacy of long term
intermittent administration of a poorly absorbable antibiotic (rifaximin) in obtaining …

Rifaximin has been reported to be effective for the treatment of hepatic encephalopathy (HE)
in Europe. However, it is unknown whether Rifaximin is effective for the treatment of HE in …

Fifty-eight patients, 30 males and 28 females, aged between 42 and 60 years I mean age 57
years) suffering from cirrhosis of the liver with signs and symptoms of portosystemic …

Hepatic encephalopathy is a neuropsychological syndrome due to biochemical disturbance
of brain function in advanced liver disease patients. Diagnosis and treatment of the condition …